Beatriz Jacob
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Beatriz Jacob has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Eliane Candiani Arantes
University of São Paulo
3 shared publications - Isabela Gobbo Ferreira
Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, Brazil
3 shared publications - Isadora Sousa de Oliveira
Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
3 shared publications - Manuela Berto Pucca
Graduate Program in Bioscience and Biotechnology Applied to Pharmacy, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 19060-900, Brazil
3 shared publications - Felipe Augusto Cerni
Medical School, Federal University of Roraima (UFRR), Boa Vista 69310-000, Roraima, Brazil
2 shared publications - Francielle Almeida Cordeiro
Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8524
Novel Biochemical Findings from Bothrops marajoensis Venom
Bothrops marajoensis is a Brazilian pit viper whose venom remains poorly characterized compared with those of other medically important Bothrops species. In the present study, we performed a comparative biochemical characterization of B. marajoensis venom with six additional Bothrops venoms (B. alternatus, B. atrox, B. jararaca, B. jararacussu, B. moojeni, and B. neuwiedi). Venoms were analyzed by reversed-phase chromatography, electrophoresis, immunorecognition by commercial bothropic antivenom, phosphodiesterase activity, and their effects on the viability of differentiated C2C12 myotubes. Chromatographic and electrophoretic analyses revealed a largely conserved overall venom composition among species, with qualitative differences, although quantitative differences in protein relative abundance were evident. Bothropic antivenom recognized all venoms, indicating broad antigenic cross-reactivity despite venom variation. B. marajoensis exhibited intermediate phosphodiesterase (PDE) activity relative to other species evaluated, confirming functional variability among Bothrops venoms. In the cell viability assay, B. marajoensis displayed comparatively low apparent cytotoxicity toward differentiated C2C12 myotubes, maintaining higher cell viability than highly myotoxic venoms such as those of B. jararacussu and B. moojeni. These findings expand the biochemical characterization of B. marajoensis venom and demonstrate that, although venoms share the conserved toxin repertoire typical for Bothrops genus, quantitative differences influence its biological activities, preserving broad recognition by bothropic antivenom.
- 24 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8524
Open AccessNovel Biochemical Findings from Bothrops marajoensis Venom
Bothrops marajoensis is a Brazilian pit viper whose venom remains poorly characterized compared with those of other medically important Bothrops species. In the present study, we performed a comparative biochemical characterization of B. marajoensis venom with six additional Bothrops venoms (B. alternatus, B. atrox, B. jararaca, B. jararacussu, B. moojeni, and B. neuwiedi). Venoms were analyzed by reversed-phase chromatography, electrophoresis, immunorecognition by commercial bothropic antivenom, phosphodiesterase activity, and their effects on the viability of differentiated C2C12 myotubes. Chromatographic and electrophoretic analyses revealed a largely conserved overall venom composition among species, with qualitative differences, although quantitative differences in protein relative abundance were evident. Bothropic antivenom recognized all venoms, indicating broad antigenic cross-reactivity despite venom variation. B. marajoensis exhibited intermediate phosphodiesterase (PDE) activity relative to other species evaluated, confirming functional variability among Bothrops venoms. In the cell viability assay, B. marajoensis displayed comparatively low apparent cytotoxicity toward differentiated C2C12 myotubes, maintaining higher cell viability than highly myotoxic venoms such as those of B. jararacussu and B. moojeni. These findings expand the biochemical characterization of B. marajoensis venom and demonstrate that, although venoms share the conserved toxin repertoire typical for Bothrops genus, quantitative differences influence its biological activities, preserving broad recognition by bothropic antivenom.
- Open Access
- 8 July 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1610
Investigating the Antimicrobial Activity of Anuran Toxins
Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.
- 8 July 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1610
Open AccessInvestigating the Antimicrobial Activity of Anuran Toxins
Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.
- Open Access
Harnessing the Power of Venomous Animal-Derived Toxins against COVID-19
Animal-derived venoms are complex mixtures of toxins triggering important biological effects during envenomings. Although venom-derived toxins are known for their potential of causing harm to victims, toxins can also act as pharmacological agents. During the COVID-19 pandemic, there was observed an increase in in-depth studies on antiviral agents, and since, to date, there has been no completely effective drug against the global disease. This review explores the crosstalk of animal toxins and COVID-19, aiming to map potential therapeutic agents derived from venoms (e.g., bees, snakes, scorpions, etc.) targeting COVID-19.
Open AccessHarnessing the Power of Venomous Animal-Derived Toxins against COVID-19
Animal-derived venoms are complex mixtures of toxins triggering important biological effects during envenomings. Although venom-derived toxins are known for their potential of causing harm to victims, toxins can also act as pharmacological agents. During the COVID-19 pandemic, there was observed an increase in in-depth studies on antiviral agents, and since, to date, there has been no completely effective drug against the global disease. This review explores the crosstalk of animal toxins and COVID-19, aiming to map potential therapeutic agents derived from venoms (e.g., bees, snakes, scorpions, etc.) targeting COVID-19.